EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis

Jerry Yu, Rajneesh Kaur, Femi Emmanuel Ayeni iD, Guy D Eslick, Senarath Edirimanne

Hormone and Metabolic Research · 2023-06 · 55 (06) · 379-387

DOI: 10.1055/a-2084-3408 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Hormone and Metabolic Research, online erschienen am 09.06.2023. Verfasst von Jerry Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Medical School, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Atrial Fibrillation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We performed a systematic review and meta-analysis of the literature regarding cardiovascular outcomes of differentiated thyroid cancer (DTC) patients who are on long term thyroid stimulating hormone suppression. Searches were carried out using Prisma guidelines in Medline, Embase, CENTRAL, CINAHL and Scopus databases. Eligible papers were those which investigated discrete cardiovascular clinical outcomes in TSH suppressed patients and meta-analysis of selected studies was performed using Revman 5.4.1. We found a total of 195 879 DTC patients with median length to follow up of 8.6 years (range 5–18.8 years). Analysis showed DTC patients to be at higher risk of atrial fibrillation (HR 1.58, 95% CI 1.40, 1.77), stroke (HR 1.14, 95% CI 1.09, 1.20) and all-cause mortality (HR 2.04, 95% CI 1.02, 4.07). However, there was no difference in risk of heart failure, ischemic heart disease or cardiovascular mortality. These findings suggest that degree of TSH suppression must be titrated to accommodate risk of cancer recurrence and cardiovascular morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAtrial FibrillationHumansNeoplasm Recurrence, LocalThyrotropin

Substanzen

Thyrotropin

Autor:innen und Institutionen

  • Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Nepean Institute of Academic Surgery, Nepean Clinical School, The University of Sydney, Sydney, Australia.
  • Dept of Surgery, Nepean Hospital, Penrith, Australia.

ORCID-Profile: Femi Emmanuel Ayeni

Zitieren

APA

Yu, J., Kaur, R., Ayeni, F. E., Eslick, G. D., & Edirimanne, S. (2023). Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research, 55(06), 379-387. https://doi.org/10.1055/a-2084-3408

Vancouver

Yu J, Kaur R, Ayeni FE, Eslick GD, Edirimanne S. Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research. 2023;55(06):379-387. doi:10.1055/a-2084-3408

BibTeX
@article{Yu2023,
  author = {Yu, Jerry and Kaur, Rajneesh and Ayeni, Femi Emmanuel and Eslick, Guy D and Edirimanne, Senarath},
  title = {Cardiovascular Outcomes of Differentiated Thyroid Cancer Patients on Long Term TSH Suppression: A Systematic Review and Meta-Analysis},
  journal = {Hormone and Metabolic Research},
  year = {2023},
  volume = {55},
  number = {06},
  pages = {379--387},
  doi = {10.1055/a-2084-3408}
}
Kostenlos starten →